Cart is empty Dr. Simrit Parmar, an associate professor in the College of Medicine at Texas A&M University and founder of the clinical-stage biotech company Cellenkos Inc. in Houston, has invented a new cell therapy that shows strong promise for the treatment of amyotrophic lateral sclerosis (ALS), aplastic anemia and other devastating diseases.
Leave A Comment